Clinical trial

Long-term Effectiveness of the Antiobesity Medication Phentermine

NCT05176626

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-06-30

PhasePHASE4

Study timeline

Study start (actual)2022-06-30Date precision: day

Registry last updated2026-03-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Obesity; Drugunresolved

Lifestyle, Healthyunresolved

Interventions

Online Lifestyle Behavioral TherapyBEHAVIORAL

Phentermine Hydrochloride 8 MGDRUG · verified · RxNorm: phentermine hydrochloride 8 MG

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Johns Hopkins Universitycollaborator

Kaiser Permanentecollaborator

HealthPartners Institutecollaborator

The University of Texas Health Science Center, Houstoncollaborator

Biomedical Research Institute of New Mexicocollaborator

WW International Inccollaborator

KVK-Tech, Inc.collaborator

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

Los AngelesCalifornia, United States1 Winston-SalemNorth Carolina, United States1 Saint Louis ParkMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05176626 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.